For Investors

Ethos informs investment decisions with cogent, reasoned analysis of the clinical and commercial value of new technologies, based on:

Unmet Clinical and/or Professional Need

Plausibility or Attractiveness of Technology or Product

Acceptance of Technology or Product in Clinical Practice

Likelihood That Valid Proof of Concept Is Achievable

Size and Growth of theAddressable Market

Attractiveness of BusinessModel

Potential for Sustainable Competitive Advantage

Challenges of Regulatory/Reimbursement Environment

We offer expert guidance for institutional and private investors in pharmaceuticals, medical devices, and biotechnology

Commercial Value & Technology Assessment >>

Ethos LifeScience Advisors 2014 SITEMAP CONTACT US